Affordable Access

deepdyve-link
Publisher Website

Corrigendum to "Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study" [Clinical Therapeutics 40 (12) (2018) 2077-2087].

Authors
  • Kresa-Reahl, Kiren1
  • Repovic, Pavle2
  • Robertson, Derrick3
  • Okwuokenye, Macaulay4
  • Meltzer, Leslie4
  • Mendoza, Jason P5
  • 1 Providence Multiple Sclerosis Center, Portland, OR, USA.
  • 2 Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA, USA.
  • 3 USF Multiple Sclerosis Center, Tampa, FL, USA.
  • 4 Biogen, Cambridge, MA, USA.
  • 5 Biogen, Cambridge, MA, USA. Electronic address: [email protected]
Type
Published Article
Journal
Clinical therapeutics
Publication Date
Dec 01, 2019
Volume
41
Issue
12
Pages
2662–2662
Identifiers
DOI: 10.1016/j.clinthera.2019.06.001
PMID: 31255296
Source
Medline
Language
English
License
Unknown
Report this publication

Statistics

Seen <100 times